09:00-10:00 Plenary Lecture: Liquid biopsy for cancer screening



Michael Neumaier

10:00-10:30 COFFEE BREAK 
10:30-12:00 S1. The role of clinical laboratories in diagnosis and manegement of cancer  Satellite Symposium  Satellite Symposium  
Epigenetics in cancer diagnostics. Current knowledge and future perspectives



Emin Kansu

The role of laboratory in determination and management of anticancer therapies



Aldo Tomasi

The impact of flow cytometry in clinical laboratory



Brent L. Wood

13:30-15:00 S2. Biomarkers of heart failure and prognosis S3. The utility of biomarkers in neurological disorders S10. WASPALM Symposia
The utility of high sensitive troponins in early diagnosis or rule out of AMI



Jordi Ordonez Llanos

Biomarkers of brain injury and neurodegenerative diseases



to be announced

Perspectives on women’s health care: Novel approaches for rare diseases, aging and cancer



Cinzia Marchese      

Prognostic markers of heart failure



Mehmet Birhan Yilmaz 

Cerebrospinal fluid biomarkers in diagnostics of neurodegenerative and inflammatory diseases



Kaj Blennow

Inositol metabolites as biomarkers of peripheral complications in insulin resistant and diabetes patients



Mariano Bizzarri    

The diagnosis and managemet of demantia



Sylvain Lehmann

Usefulness of intraoperative parathyroid hormone monitoring during minimally invasive video-assisted parathyroidectomy



Elisabetta Stenner

15:00-15:30 COFFEE BREAK
15:30-17:00 S5. Detecting kidney disease: From proteomics to the clinical laboratory

S22. Laboratory testing guideline in the intensive care unit    

S7. The rise and fall of total error concept in laboratory medicine
Proteomics for kidney diseases



to be announced

The role of laboratory medicine in intensive care unit

Ismail Cinel

Uncertainty or total allowable error: The big debate



Anders Kallner 

Urinary biomarkers in kidney transplantation: Application of Mass Spectrometry to measure peptides and proteins



Halide Akbas

Inflammation versus sepsis: Focus on biomarkers

Michael Meisner

From measurement to diagnosis: Uncertainty in laboratory medicine



Elvar Theodorsson

The clinical laboratory and kidney disease



Edmund J. Lamb

TDM of antibiotics

Paul M. Tulkens

Oral Presentations 
17:00-17:30 COFFEE BREAK 
17:30-18:30 S8. Endocrinologist and laboratorian, a friendship under construction S9. Personalized medicine S4. Diagnostic approach to hemostasis disorders
What do the endocrinologists expect from laboratory?



Ilhan Satman

The role of laboratory medicine in personalized and precision medicine



Mario Pazzagli       

Coagulation testing and new oral anticoagulants



Sophie Testa     

The role of laboratory in metabolic bone disease



Howard Morris

Personalized reference intervals



Yesim Ozarda

Biomarkers of hemostasis and thrombosis



Tilman Hacken

Diagnostic approach to hemostasis disorders



Hugo ten Cate